Breaking News Instant updates and real-time market news.

IMMU

Immunomedics

$25.40

-0.09 (-0.35%)

08:03
07/18/18
07/18
08:03
07/18/18
08:03

Immunomedics: FDA accepts BLA, grants priority review for sacituzumab govitecan

Immunomedics announced that the FDA has accepted the company's Biologics License Application, or BLA, for filing and granted Priority Review for sacituzumab govitecan for the treatment of patients with metastatic triple-negative breast cancer, or mTNBC, who previously received at least two prior therapies for metastatic disease. The PDUFA target action date is January 18, 2019. If approved, sacituzumab govitecan would be the first and only ADC approved for the treatment of mTNBC. The filing is based on Phase 1/2 data of sacituzumab govitecan in mTNBC.

IMMU Immunomedics
$25.40

-0.09 (-0.35%)

01/24/18
JEFF
01/24/18
NO CHANGE
Target $22
JEFF
Buy
Immunomedics price target raised to $22 from $16 at Jefferies
Jefferies analyst Matthew Andrews raised his price target for Immunomedics to $22 saying his analysis suggests a 98% FDA approval probability of IMMU-132. The shares could be worth $27 on approval, Andrews tells investors in a research note. He keeps a Buy rating on Immunomedics.
05/17/18
WELS
05/17/18
NO CHANGE
WELS
Immunomedics data could support breakthrough designation, says Wells Fargo
Wells Fargo analyst Jim Birchenough believes the abstract data for IMMU132 in hormone-receptor breast cancer could support breakthrough designation and a potential fast-to-market path for an indication that is up to three times bigger than the advanced indication of triple negative breast cancer. The analyst reiterates an Overweight rating on shares of Immunomedics.
06/04/18
WELS
06/04/18
NO CHANGE
Target $31
WELS
Outperform
Immunomedics price target raised to $31 from $25 at Wells Fargo
Wells Fargo analyst Jim Birchenough raised his price target for Immunomedics to $31 from $25 following review of updated data at the American Society of Clinical Oncology meeting for TROP2-targeted antibody drug conjugate in relapsed/refractory ER+ breast cancer. Overall, the analyst believes that response rate of 31% with median response duration of 7.4 months is in line with that supporting breakthrough designation and accelerated approval filing in triple negative breast cancer, and believes the shares are undervalued relative to aggregate opportunity in TNBC, ER+ breast cancer, urothelial cancer and other TROP2+ cancers. Birchenough reiterates an Outperform rating on the stock.
06/06/18
RILY
06/06/18
INITIATION
Target $53
RILY
Buy
Immunomedics initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Madhu Kumar started Immunomedics with a Buy rating and $53 price target and added the shares to his firm's Alpha Generator list. The company has the makings of a blockbuster cancer drug, Kumar tells investors in a research note.

TODAY'S FREE FLY STORIES

PINC

Premier

$38.38

0.24 (0.63%)

09:15
08/20/18
08/20
09:15
08/20/18
09:15
Hot Stocks
Premier to provide operational transformation consulting to UofL Hospital, ULP »

Premier has expanded its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 05

    Sep

  • 14

    Sep

OPTT

Ocean Power

$0.76

0.0501 (7.06%)

, E

Eni SpA

$36.28

0.12 (0.33%)

09:14
08/20/18
08/20
09:14
08/20/18
09:14
Hot Stocks
Ocean Power ships PB3 PowerBuoy to Eni SpA »

Ocean Power (OPTT)…

OPTT

Ocean Power

$0.76

0.0501 (7.06%)

E

Eni SpA

$36.28

0.12 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SODA

SodaStream

$129.89

1.12 (0.87%)

, PEP

PepsiCo

$114.98

0.7 (0.61%)

09:14
08/20/18
08/20
09:14
08/20/18
09:14
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: SodaStream…

SODA

SodaStream

$129.89

1.12 (0.87%)

PEP

PepsiCo

$114.98

0.7 (0.61%)

TSLA

Tesla

$305.33

-30.13 (-8.98%)

MIXT

MiX Telematics

$15.09

-0.17 (-1.11%)

NKE

Nike

$79.73

-0.32 (-0.40%)

BBOX

Black Box

$1.64

0.09 (5.81%)

LCI

Lannett

$13.50

-0.25 (-1.82%)

INFY

Infosys

$21.09

0.095 (0.45%)

STZ

Constellation Brands, also tag STZ.B

$203.90

1.47 (0.73%)

NWS

News Corp

$14.40

0.1 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 28

    Aug

  • 12

    Sep

  • 02

    Oct

  • 28

    Oct

  • 29

    Oct

AKAO

Achaogen

$5.91

0.21 (3.68%)

09:13
08/20/18
08/20
09:13
08/20/18
09:13
Recommendations
Achaogen analyst commentary  »

Achaogen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 31

    Aug

TSLA

Tesla

$305.33

-30.13 (-8.98%)

09:13
08/20/18
08/20
09:13
08/20/18
09:13
Recommendations
Tesla analyst commentary  »

Tesla price target cut to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

RADA

RADA Electronic

$2.52

-0.02 (-0.79%)

09:11
08/20/18
08/20
09:11
08/20/18
09:11
Hot Stocks
RADA Electronic's MHR to be delivered to the British Army »

RADA Electronic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:10
08/20/18
08/20
09:10
08/20/18
09:10
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

LTBR

Lightbridge

$0.87

0.004 (0.46%)

09:08
08/20/18
08/20
09:08
08/20/18
09:08
Hot Stocks
Lightbridge CFO Linda Zwobota to retire, Larry Goldman to succeed »

Lightbridge announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

4.16 (1.95%)

09:05
08/20/18
08/20
09:05
08/20/18
09:05
Downgrade
Apple rating change  »

Apple downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:05
08/20/18
08/20
09:05
08/20/18
09:05
General news
Treasury Action: yields have extended early declines »

Treasury Action: yields…

JCP

J.C. Penney

$1.79

0.025 (1.42%)

09:04
08/20/18
08/20
09:04
08/20/18
09:04
Hot Stocks
J.C. Penney unveils new, exclusive big & tall brand with Shaquille O'Neal »

Building on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICHR

Ichor Holdings

$21.32

-0.57 (-2.60%)

09:04
08/20/18
08/20
09:04
08/20/18
09:04
Hot Stocks
Ichor Holdings announces $50M increase to share repurchase program »

Ichor Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

IVAC

Intevac

$5.03

0.225 (4.69%)

09:03
08/20/18
08/20
09:03
08/20/18
09:03
Hot Stocks
Intevac announces $10M expansion of existing $30M share repurchase program »

Intevac announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXP

Boston Properties

$132.14

0.5 (0.38%)

09:02
08/20/18
08/20
09:02
08/20/18
09:02
Recommendations
Boston Properties analyst commentary  »

Boston Properties price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RICK

RCI Hospitality

$32.61

0.36 (1.12%)

09:02
08/20/18
08/20
09:02
08/20/18
09:02
Hot Stocks
RCI Hospitality to acquire Blush Gentlemen's Club & Sports Bar for $15M »

RCI Hospitality announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWRE

Guidewire

$95.23

-1.47 (-1.52%)

08:58
08/20/18
08/20
08:58
08/20/18
08:58
Hot Stocks
Guidewire contributes to report on cyber insurance market »

Guidewire Software helped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 12

    Sep

AAPL

Apple

$217.65

4.16 (1.95%)

, TSLA

Tesla

$305.33

-30.13 (-8.98%)

08:55
08/20/18
08/20
08:55
08/20/18
08:55
Options
Notable open interest changes for August 20th »

Friday's total…

AAPL

Apple

$217.65

4.16 (1.95%)

TSLA

Tesla

$305.33

-30.13 (-8.98%)

BABA

Alibaba

$172.76

0.78 (0.45%)

FB

Facebook

$173.78

-0.98 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 23

    Aug

  • 06

    Sep

  • 10

    Sep

  • 18

    Sep

  • 29

    Oct

PAY

Verifone

$23.04

0.01 (0.04%)

08:54
08/20/18
08/20
08:54
08/20/18
08:54
Hot Stocks
Breaking Hot Stocks news story on Verifone »

Verifone trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQDA

Liquidia Technologies

$14.30

-0.12 (-0.83%)

08:52
08/20/18
08/20
08:52
08/20/18
08:52
Initiation
Liquidia Technologies initiated  »

Liquidia Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$9.56

0.04 (0.42%)

08:51
08/20/18
08/20
08:51
08/20/18
08:51
Recommendations
Ford analyst commentary  »

Ford risks high, but so…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

TNDM

TNDM

, DXCM

DexCom

$130.93

2.61 (2.03%)

08:51
08/20/18
08/20
08:51
08/20/18
08:51
Recommendations
TNDM, DexCom analyst commentary  »

Tandem Diabetes price…

TNDM

TNDM

DXCM

DexCom

$130.93

2.61 (2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 27

    Aug

  • 12

    Sep

  • 13

    Sep

  • 20

    Sep

  • 21

    Sep

08:50
08/20/18
08/20
08:50
08/20/18
08:50
General news
Fedspeak from Atlanta Fed dove Bostic »

Fedspeak from Atlanta Fed…

VERI

Veritone

$11.41

0.11 (0.97%)

08:49
08/20/18
08/20
08:49
08/20/18
08:49
Conference/Events
Veritone to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

VMC

Vulcan Materials

$110.31

0.46 (0.42%)

08:47
08/20/18
08/20
08:47
08/20/18
08:47
Recommendations
Vulcan Materials analyst commentary  »

Vulcan Materials price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 06

    Nov

MLCO

Melco Resorts & Entertainment

$22.08

0.56 (2.60%)

08:47
08/20/18
08/20
08:47
08/20/18
08:47
Hot Stocks
Melco Resorts & Entertainment subsidiary provides update on IPO »

Studio City International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.